Comment re: Temozolomide preferentially depletes cancer stem cells

Cancer Res. 2009 Aug 1;69(15):6364; author reply 6365. doi: 10.1158/0008-5472.CAN-09-0036. Epub 2009 Jul 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Alkylating / pharmacology*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / pathology*
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / pharmacology
  • Glioblastoma / drug therapy
  • Glioblastoma / pathology*
  • Humans
  • Magnetic Resonance Imaging
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / pathology
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide